Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | MMP12 | P39900 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9913287 | 0.81 | EPHX1 (0.40) | KDM4CTSHRALDH1A1ELANEEPHX1 | |
| SCHEMBL18125958 | 0.79 | KDM4C (0.48) | KDM4CTSHRALDH1A1KDM4EMAPT | |
| SCHEMBL11683093 | 0.78 | EPHX1 (0.44) | KDM4CTSHRALDH1A1ELANEEPHX1 | |
| Acetic Acid SCHEMBL25309382 | 0.78 | ELANE (0.33) | KDM4CALDH1A1ELANEEPHX1MAPT | |
| SCHEMBL10493720 | 0.77 | TSHR (0.40) | KDM4CTSHRALDH1A1ELANEEPHX1 | |
| SCHEMBL14040406 | 0.74 | KDM4C (0.45) | KDM4CTSHRALDH1A1KDM4EMAPT | |
| SCHEMBL8471567 | 0.74 | CRBN (0.39) | ALDH1A1ELANEEPHX1KDM4ECA2 | |
| SCHEMBL29420093 | 0.74 | KDM4C (0.45) | KDM4CTSHRALDH1A1KDM4EMAPT | |
| SCHEMBL1132708 | 0.74 | KDM4C (0.45) | KDM4CTSHRALDH1A1KDM4ECA2 | |
| SCHEMBL11683952 | 0.74 | EPHX1 (0.36) | ELANEEPHX1KDM4ECA2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083865-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2026-03-26 | — | — | US | claimed |
| US-20250304643-A1 | PEPTIDE DUAL AGONISTS OF GIPR AND GLP2R | BAINAN BIOTECH APS (DK) | 2025-10-02 | — | — | US | claimed |
| EP-4583917-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B Pharmaceuticals GmbH (DE) | 2025-07-16 | — | — | EP | claimed |
| CN-119923279-A | Prostate Specific Membrane Antigen (PSMA) ligands and uses thereof | 3B制药有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119823226-A | Application of trichoderma hook antibacterial peptide in prevention and treatment of potato late blight and pesticide | 甘肃农业大学 | 2025-04-15 | — | — | CN | claimed |
| CN-118027154-B | Trichoderma hook T21 antibacterial peptide BI and preparation method and application thereof | 甘肃农业大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118843639-A | Peptide dual agonists of GIPR and GLP2R | 白南生物技术有限公司 | 2024-10-25 | — | — | CN | claimed |
| EP-4448097-A1 | PEPTIDE DUAL AGONISTS OF GIPR AND GLP2R | Bainan Biotech ApS (DK) | 2024-10-23 | — | — | EP | claimed |
| CN-117986326-B | Trichoderma hook T21 antibacterial peptide BII and preparation method and application thereof | 甘肃农业大学 | 2024-09-17 | — | — | CN | claimed |
| CN-117986326-A | Trichoderma hook T21 antibacterial peptide BII and preparation method and application thereof | 甘肃农业大学 | 2024-05-07 | — | — | CN | claimed |
| WO-2024052431-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2024-03-14 | — | — | WO | claimed |
| WO-2023111273-A1 | PEPTIDE DUAL AGONISTS OF GIPR AND GLP2R | BAINAN BIOTECH APS (DK) | 2023-06-22 | — | — | WO | claimed |
| CN-114981295-A | Polypeptide compound and application thereof | 联邦生物科技(珠海横琴)有限公司 | 2022-08-30 | — | — | CN | claimed |
| WO-2005055947-A2 | ENLARGEMENT OF MUCOCUTANEOUS OR CUTANEOUS ORGANS AND SITES WITH TOPICAL COMPOSITIONS | YU RUEY J (US) | 2005-06-23 | — | — | WO | claimed |
| US-20260083865-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2026-03-26 | — | — | US | disclosed |
| EP-4143179-B1 | AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS FOR THE TREATMENT OF CANCER | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-10-22 | — | — | EP | disclosed |
| US-20250304643-A1 | PEPTIDE DUAL AGONISTS OF GIPR AND GLP2R | BAINAN BIOTECH APS (DK) | 2025-10-02 | — | — | US | disclosed |
| EP-0015772-A1 | N-(2-((acylaminoacylamino or aminoacylamino)phenyl)-4-hydroxy-5-pyrimidinylcarbonyl)cephalosporin compounds, processes for their production, and compositions containing the same | WARNER-LAMBERT COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |
| EP-0015771-A1 | N-(6-((acylaminoacylamino or aminoacylamino)phenyl)-1,2-dihydro-2-oxonicotinyl) cephalosporin compounds, processes for their production, and compositions containing the same | WARNER-LAMBERT COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |
| EP-0015773-A2 | N-(6-((acylaminoacylamino or aminoacylamino)phenyl) 1,2-dihydro-2-oxonicotinyl)penicillin compounds, processes for their production and compositions containing them | WARNER-LAMBERT COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083865-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | KLK3, FOLH1, PSMA1 | KDM4C 3667/4885TSHR 540/4885ALDH1A1 1372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.